We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$821B
AUM Growth
+$62.3B
Cap. Flow
+$23.5B
Cap. Flow %
2.87%
Top 10 Hldgs %
16.79%
Holding
7,579
New
751
Increased
3,314
Reduced
2,056
Closed
652
Avg Time Held Equity + Options
17.5 quarters
Top 10 Avg Time Held Equity + Options
16.2 quarters
Top 20 Avg Time Held Equity + Options
12.2 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
16.2 quarters
Top 20 Avg Time Held Equity only
14.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.28%
2 Technology 17.17%
3 Healthcare 10.79%
4 Financials 9.36%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VAPO
7126
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$0 ﹤0.01%
4
– –
2018 Q4
17 quarters
MIRO
7127
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
– –
-1,645
Closed -$5K –
TBCP
7128
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
– –
-31,530
Closed -$308K –
FSRX
7129
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
– –
-100,781
Closed -$1.01M –
CCVI
7130
DELISTED
Churchill Capital Corp VI
CCVI
– –
-400,000
Closed -$4M –
CORR
7131
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$0 ﹤0.01%
44
– –
2016 Q2
27 quarters
PTRS
7132
DELISTED
Partners Bancorp Common Stock
PTRS
$0 ﹤0.01%
16
– –
2020 Q2
11 quarters
VMW
7133
CALL
DELISTED
VMware, Inc
VMW
– –
-15,000
Closed -$1.84M –
LHC
7134
DELISTED
Leo Holdings Corp. II
LHC
– –
-148,600
Closed -$1.5M –
APRN
7135
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$0 ﹤0.01%
+2
New +$22
2022 Q4
1 quarter
ACER
7136
DELISTED
Acer Therapeutics Inc
ACER
$0 ﹤0.01%
48
– –
2017 Q4
21 quarters
ICPT
7137
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-4,800
Closed -$59K –
AAC
7138
DELISTED
Ares Acquisition Corporation
AAC
– –
-1,392,554
Closed -$14M –
FRGI
7139
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$0 ﹤0.01%
3
– –
2016 Q4
25 quarters
LTRPA
7140
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$0 ﹤0.01%
120
-26
-18% -$28
2015 Q3
30 quarters
RVLP
7141
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$0 ﹤0.01%
3
– –
2018 Q4
17 quarters
CCV
7142
DELISTED
Churchill Capital Corp V
CCV
– –
-50,000
Closed -$497K –
ASPY
7143
DELISTED
ASYMmetric Smart S&P 500 ETF
ASPY
– –
-165
Closed -$4K –
CGRN
7144
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$0 ﹤0.01%
135
– –
2014 Q2
35 quarters
LMNL
7145
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
– –
0
– –
2021 Q4
5 quarters
INFI
7146
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$0 ﹤0.01%
1,147
-1,523
-57% -$676
2018 Q4
17 quarters
NSTD
7147
DELISTED
Northern Star Investment Corp. IV
NSTD
– –
-2,475,747
Closed -$24.9M –
NSTC
7148
DELISTED
Northern Star Investment Corp. III
NSTC
– –
-2,983,670
Closed -$30M –
SABRP
7149
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
– –
-1,600
Closed -$135K –
GMVD
7150
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
– –
-60,164
Closed -$196K –

Similar funds

JP Morgan Chase's Q1 2023 Portfolio in Review

As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
  • JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
  • JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
  • JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
  • JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.